Derek Hicks
Fortune : 842 483 $ au 31/05/2026
Fortune : 842 483 $ au 31/05/2026
Derek Hicks currently works at Rezo Therapeutics, Inc., as Chief Executive Officer from 2025.
Mr. Hicks also formerly worked at Spark Therapeutics, Inc., as Head-Business Development from 2020 to 2021 and Intellia Therapeutics, Inc., as Chief Business Officer & Executive Vice President.
Mr. Hicks received his undergraduate degree and graduate degree from the University of Connecticut and Masters Business Admin degree from Kelley School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/01/2025 | 59 878 ( 0,04% ) | 842 483 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Directeur Général | 12/08/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national